Tag: circulating tumor cells market research

  • 2024 Circulating Tumor Cells Market Outlook: Size, Share, and Key Growth Drivers

    2024 Circulating Tumor Cells Market Outlook: Size, Share, and Key Growth Drivers

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Growth Rate is the Circulating Tumor Cells Market Anticipated to Experience from 2024-2033?

    The market size for circulating tumor cells has seen a rapid increase in recent times. The market is projected to expand from $10.79 billion in 2023 to $12.21 billion in 2024, with a compound annual growth rate (CAGR) of 13.1%. The expansion observed in the historical time frame is due to several factors such as the rising incidence and prevalence of cancer, the beneficial role of these cells in cancer staging, the advent of liquid biopsy, a preference from patients for less invasive testing methods, supportive regulations for liquid biopsies, and an emphasis on detecting cancer in its early stages.

    Expectations are high for a substantial increase in the size of the circulating tumor cells market in the coming years. It is predicted to expand to a whopping $19.45 billion by 2028, boasting a compound annual growth rate (CAGR) of 12.3%. The expected growth during this forecast period can be traced back to several factors including the implementation of point-of-care ctc testing, the adoption of microfluidics, the concentrated focus on rare forms of cancer, the standardization of ctc assays, the expansion of ctc-centric clinical trials and growth within both economic and emerging markets. Key trends that will steer the market growth during the forecast period encompass novel techniques in ctc isolation, governmental support in funding ctc research, tech advancements in ctc detection, liquid biopsy use in cancer monitoring, integration with single-cell analysis and the burgeoning convergence with artificial intelligence (AI).

    Claim Your Free Sample of the Global Circulating Tumor Cells Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

    What Are the Significant Influencers of Growth in the circulating tumor cells Market?

    The escalating prevalence of cancer is anticipated to fuel the expansion of the circulating tumor cells market. Cancer is a condition characterized by unchecked growth and dissemination of certain body cells. Circulating tumor cells play a crucial role in the early identification and treatment of cancer, therefore, upturning rates of cancer stimulate the rising of the circulating tumor cells market. For example, in January 2023, the American Cancer Society Inc., a volunteer health organization based in the US, projected that by 2021, there will be 1.9 million fresh cancer diagnoses and 608,570 cancer-related deaths. Consequently, the amplified occurrence of cancer is propelling the momentum of the circulating tumor cells market.

    What Key Segments Define the Circulating Tumor Cells Market?

    1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

    2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

    3) By Specimen: Blood, Bone Marrow, Other Body Fluids

    4) By Application: Clinical Or Liquid Biopsy, Research

    What Are the Key Developments Shaping the Circulating Tumor Cells Market?

    In the circulating tumor cells market, one of the emerging trends is the emphasis on product innovation. To solidify their market presence, leading companies in the circulating tumor cells industry are actively creating novel products. For example, Menarini Silicon Biosystems, a firm situated in Italy and specializing in liquid biopsy and single-cell technologies, introduced the CellMag CTC Epithelial Cell kit in February 2021. With ferrofluid technology, the kit simplifies the manual immuno-magnetic enrichment and staining process for rare CTCs (circulating tumor cells). This kit serves as an efficient and straightforward protocol for liquid biopsy labs, facilitating the standardisation of sample preparation.

    Order Now for Fast Delivery of Your Circulating Tumor Cells Market Report!

    https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

    What Regions Are Driving Expansion in the Circulating Tumor Cells Market?

    North America was the largest region in the circulating tumor cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Circulating Tumor Cells Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the circulating tumor cells market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Circulating Tumor Cells Market Include

    1. Circulating Tumor Cells Market Executive Summary

    2. Circulating Tumor Cells Market Segments

    3. Circulating Tumor Cells Market Size And Template Market Growth Rate

    4. Key Circulating Tumor Cells Market Trends

    5. Major Circulating Tumor Cells Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Circulating Tumor Cells Market

    26. Top Circulating Tumor Cells Companies

    27. Circulating Tumor Cells Market Opportunities And Strategies

    28. Circulating Tumor Cells Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Circulating Tumor Cells Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Circulating Tumor Cells Global Market Report 2024, the circulating tumor cells market is expected to show promising growth in the forecast period.

    Rising Cancer Incidence Drives Surge In Circulating Tumor Cells Market

    • Growing Cancer Incidence: The escalating incidence of cancer fuels the expansion of the circulating tumor cells market. According to the American Cancer Society Inc., approximately 1.9 million new cancer cases were diagnosed by 2021.
    • Market Players: Major companies such as Precision Medicine Group LLC, Bio-Techne Corporation, and Biocept Inc., among others, contribute significantly to market growth.

    Increasing Focus On Liquid Biopsy Products To Provide Reliable Services To Their Customers

    • Innovative Products: Key players in the circulating tumor cells market concentrate on oncology liquid biopsy products to enhance revenue streams.
    • BillionToOne Inc.’s Initiative: In June 2022, BillionToOne Inc. introduced oncology liquid biopsy products, NorthStar Select and NorthStar Response, aiming for precise somatic mutation profiling and treatment response monitoring.

    Agilent Technologies Enhances Cancer Diagnostics Portfolio With Acquisition Of Resolution Bioscience Inc.

    • Strategic Acquisition: Agilent Technologies Inc. acquired Resolution Bioscience Inc. in April 2021, amplifying its capabilities in cancer diagnostics.
    • Resolution Bioscience Inc.: Known for its next-generation sequencing-based oncology solutions, Resolution Bioscience Inc. adds innovative technology to Agilent’s repertoire.

    Market Segmentation and Regional Dynamics

    • Segmentation: The circulating tumor cells market is categorized by product (kits and reagents, blood collection tubes, devices/systems), technology (CTC enrichment, detection, analysis), specimen (blood, bone marrow, other body fluids), and application (clinical or liquid biopsy, research).
    • Regional Dynamics: North America led the circulating tumor cells market in 2023, while Asia-Pacific is anticipated to witness the fastest growth during the forecast period.

    Forecasted Growth and Market Trends

    • Rapid Expansion: The circulating tumor cells market is poised for robust growth, reaching $19.45 billion in 2028 with a CAGR of 12.3%.
    • Driving Forces: Factors such as point-of-care CTC testing, adoption of microfluidics, and focus on rare cancer types contribute to the market’s anticipated growth.

    View More On The Circulating Tumor Cells Market Report 2024 – https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

    • Innovations and Trends: Innovations in CTC isolation techniques, government funding for CTC research, and integration with single-cell analysis are key trends shaping the market landscape.
    • Technological Convergence: The convergence of circulating tumor cells detection technologies with artificial intelligence (AI) heralds a new era in cancer diagnostics.

    Conclusion: Embracing Innovations in the Circulating Tumor Cells Market

    The circulating tumor cells market experiences remarkable growth attributed to the increasing incidence of cancer, advancements in liquid biopsy technologies, and strategic acquisitions by leading players like Agilent Technologies Inc. and Resolution Bioscience Inc. As the market expands, stakeholders witness a surge in demand for innovative solutions, driving the industry towards greater precision, efficiency, and accessibility in cancer diagnostics and treatment monitoring. With promising forecasts and relentless pursuit of excellence, the circulating tumor cells market emerges as a pivotal player in the global fight against cancer.

    Request A Sample Of The Global Circulating Tumor Cells Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=8950&type=smp